- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02046473
3D Sonographic Measurement of Volumetric Flow in Transjugular Intrahepatic Porto-Systemic Shunts
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male and female 18 years of age and older
- Have an existing TIPS (Transjugular intrahepatic porto-systemic shunt)
- Have an ultrasound ordered by your physician to evaluate your TIPS.
- Able to read, understand and sign informed consent
Exclusion Criteria:
- Under 18 years of age
- Cannot be pregnant
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Volumetric Flow in TIPS
Subjects who have TIPS (transjugular intrahepatic porto-systemic shunts) have measurements taken to determine if someone has increased blood pressure in the portal vein of the liver (portal hypertension).
Subjects who have a TIPS receive clinical ultrasounds every 3 months to determine if the TIPS is working properly.
|
Subjects who have a TIPS (transjugular intrahepatic portal-systemic shunt) for portal hypertension will undergo a clinical 3D ultrasound to determine if the TIPS is working properly.
Additional ultrasounds will be obtained during the subject's clinically ordered ultrasound(s).
These measurements will be taken by using a second ultrasound probe (plastic hand held device that is rubbed along the subject's abdomen).
15 minutes will be added to your clinically ordered exams that are completed 4 times a year.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Estimate portal blood flow within a transjugular portosystemic shunt
Time Frame: 4 years
|
To determine the number of volumes to achieve a specified variance in the measurement and to determine the reproducibility of the volume flow measurements taken at multiple locations within the stent (3 locations with 3 measurements each for a total of 9 acquisitions). The physicians will measure volume flow rate three times at three different locations in the shunt (that being proximal, medial and distal) to determine the reproducibility of the flow estimate. |
4 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Paula Novelli, M.D., University of Michigan Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HUM00054436
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Liver Disease
-
HaEmek Medical Center, IsraelTerminatedPatients With Fatty Liver DiseaseIsrael
-
Assistance Publique - Hôpitaux de ParisCompletedNonalcoholic Fatty Liver Disease (NAFLD)France
-
Massachusetts General HospitalCompletedNonalcoholic Fatty Liver Disease (NAFLD)United States
-
Columbia UniversityGlaxoSmithKlineCompletedNon-Alcoholic Fatty Liver DiseaseUnited States
-
Kowa Company, Ltd.CompletedNon-Alcoholic Fatty Liver DiseaseJapan
-
GenieBiome LimitedMicrobiota I-Centre (MagIC)Active, not recruitingMetabolic Dysfunction-Associated Fatty Liver DiseaseHong Kong
-
Miriam Vos, MDImmuron Ltd.; Advanced MR Analytics ABCompletedNonalcoholic Fatty Liver Disease (NAFLD)United States
-
Beijing Chao Yang HospitalUnknownLiver Transplantation | End Stage Liver DIseaseChina
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...RecruitingMetabolic Associated Fatty Liver Disease | Clinical FeaturesChina
-
Chinese PLA General HospitalCompletedMetabolic-dysfunction-associated Fatty Liver Disease (MAFLD)China
Clinical Trials on Volumetric Flow in TIPS
-
Consorci Sanitari de TerrassaCompleted
-
Université de SherbrookeCanadian Institutes of Health Research (CIHR)Recruiting
-
Queen's University, BelfastUniversity College, London; University of Leeds; Belfast Health and Social Care... and other collaboratorsCompletedPregnancy Related | Overweight and ObesityUnited Kingdom
-
Centre Hospitalier Universitaire, AmiensWithdrawn
-
Joslin Diabetes CenterRecruitingHypoglycemia | Cerebral Blood FlowUnited States
-
Ivoclar Vivadent AGActive, not recruitingInsufficient Dental Filling or Primary Caries (Class I or II Cavities in Premolars or Molars)Liechtenstein
-
University Hospital, MontpellierCompleted
-
Prof. Dr. Cemil Tascıoglu Education and Research...Completed
-
Stefano ZaffagniniIRCCS Istituto delle Scienze Neurologiche di Bologna; ISOKINETIC ER SRLRecruitingACL Injury | fMRI | Neuromuscular Control | Rehabilitation ExerciseItaly
-
Sang-Min LeeUnknownExtubation | Mechanical Ventilation | WeaningKorea, Republic of